Vision Genomics

Vision genomics, LLC is a biotechnology company that focuses on research and development of therapeutics for age-related eye diseases.

Business Model:

Revenue: $4.2M

Employees: 11-50

Detailed Vision Genomics Information

Geographic Data

Vision Genomics headquarters map

Address: PO Box 639

City: Kirkland

State: WA

Zip: 98083

Country: US

Financial Info

Stage:

seed

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Vision genomics, LLC is a biotechnology-based company that focuses on research and development of therapeutics for age-related eye diseases. Their company undertakes an interdisciplinary approach using big data analysis to produce working solutions for age-related eye diseases. Their primary disease of interest is Age-related macular degeneration (AMD). AMD is the leading cause of visual impairment and blindness in older adults and one of the most common causes of visual impairment worldwide. Vision Genomics, LLC is focused on operations and development of its AMD Medicine TM drug discovery with a personalized medicine platform. AMD Medicine TM was developed using the advanced genomic and transcriptomic analysis algorithms already successfully used in cancer research and precision medicine in oncology. The AMD Medicine platform contains broad databases of gene expression, genetic and epigenetic data in ocular diseases as databases of drugs with known molecular targets and effects on gene expression in a variety of tissues and cell lines. It includes advanced parametric and machine learning algorithms that screen for drugs that minimize the difference between healthy and disease states while targeting signaling pathways that are pathologically activated or down regulated and accounting for pharmacogenomic effects. For years the founding scientists have engaged in projects related to the understanding of the interplay of inter-cellular signaling pathways in age-related diseases and progeroid syndromes and have looked for interventions to modulate and delay the onset of the pathological processes resulting from and driving aging. Age-related macular degeneration (AMD) was identified as one of the disease models , in which some of the interventions may be effective. To accelerate research scientists decided to form a company and engage with the country’s top ophthalmologists to find working personalized solutions for AMD.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
4/2015 Seed Round - Deep Knowledge Group
Deep Knowledge Group
4/2015 Seed Round 1 - Deep Knowledge Group
Deep Knowledge Group
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research